To explore the impact of down-regulated Dbn1 in AD mice, Aβ and GFAP in the hippocampus were detected by immunohistochemical or immunofluorescence staining (Figure 6a and Figure 7a). This evidence concerns the gene DBN1 and Alzheimer disease.